1
|
Pradella M, Elbaz MSM, Lee DC, Hong K, Passman RS, Kholmovski E, Peters DC, Baraboo JJ, Herzka DA, Nezafat R, Edelman RR, Kim D. A comprehensive evaluation of the left atrium using cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2025; 27:101852. [PMID: 39920924 PMCID: PMC11889362 DOI: 10.1016/j.jocmr.2025.101852] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2024] [Revised: 01/09/2025] [Accepted: 01/29/2025] [Indexed: 02/10/2025] Open
Abstract
Atrial disease or myopathy is a growing concept in cardiovascular medicine, particularly in the context of atrial fibrillation, as well as amyloidosis and heart failure. Among cardiac imaging modalities, cardiovascular magnetic resonance (CMR) is particularly well suited for a comprehensive assessment of atrial myopathy, including tissue characterization and hemodynamics. The goal of this review article is to describe clinical applications and make recommendations on pulse sequences as well as imaging parameters to assess the left atrium and left atrial appendage. Furthermore, we aimed to create an overview of current and promising future emerging applications of left atrium-specific CMR pulse sequences focusing on both electrophysiologic (EP) and non-EP applications.
Collapse
Affiliation(s)
- Maurice Pradella
- Department of Radiology, University Hospital Basel, University of Basel, Basel, Switzerland
| | - Mohammed S M Elbaz
- Department of Radiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
| | - Daniel C Lee
- Department of Radiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA; Department of Internal Medicine, Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
| | - KyungPyo Hong
- Department of Radiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
| | - Rod S Passman
- Department of Internal Medicine, Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
| | - Eugene Kholmovski
- Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland, USA
| | - Dana C Peters
- Radiology & Biomedical Imaging, Yale University, New Haven, Connecticut, USA
| | - Justin J Baraboo
- Department of Biomedical Engineering, Northwestern University McCormick School of Engineering, Evanston, Illinois, USA
| | - Daniel A Herzka
- Department of Radiology, Case Western Reserve University and University Hospitals, Cleveland, Ohio, USA
| | - Reza Nezafat
- Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
| | - Robert R Edelman
- Department of Radiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA; Radiology, Northshore University Health System, Evanston, Illinois, USA
| | - Daniel Kim
- Department of Radiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA; Department of Biomedical Engineering, Northwestern University McCormick School of Engineering, Evanston, Illinois, USA.
| |
Collapse
|
2
|
Alrumayh A, Alobaida M. Catheter ablation superiority over the pharmacological treatments in atrial fibrillation: a dedicated review. Ann Med 2021; 53:551-557. [PMID: 33783271 PMCID: PMC8018546 DOI: 10.1080/07853890.2021.1905873] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/30/2020] [Accepted: 03/15/2021] [Indexed: 11/05/2022] Open
Abstract
Atrial fibrillation globally affects roughly 33.5 million people, making it the most common heart rhythm disorder. It is a crucial arrhythmia, as it is linked with a variety of negative outcomes such as strokes, heart failure and cardiovascular mortality. Atrial fibrillation can reduce quality of life because of the potential symptoms, for instance exercise intolerance, fatigue, and palpitation. There are different types of treatments aiming to prevent atrial fibrillation and improve quality of life. Currently, the primary treatment for atrial fibrillation is pharmacology therapy, however, these still show limited effectiveness, which has led to research on other alternative strategies. Catheter ablation is considered the second line treatment for atrial fibrillation when the standard treatment has failed. Moreover, catheter ablation continues to show significant results when compared to standard therapy. Hence, this review will argue that catheter ablation can show superiority over current pharmacological treatments in different aspects. It will discuss the most influential aspects of the treatment of atrial fibrillation, which are recurrence and burden of atrial fibrillation, quality of life, atrial fibrillation in the setting of heart failure and mortality and whether catheter ablation can be the first line treatment for patients with atrial fibrillation.
Collapse
Affiliation(s)
- Abdullah Alrumayh
- Department of Basic Sciences, King Saud University, Riyadh, Saudi Arabia
| | - Muath Alobaida
- Department of Basic Sciences, King Saud University, Riyadh, Saudi Arabia
| |
Collapse
|
3
|
Guttman MA, Tao S, Fink S, Tunin R, Schmidt EJ, Herzka DA, Halperin HR, Kolandaivelu A. Acute enhancement of necrotic radio-frequency ablation lesions in left atrium and pulmonary vein ostia in swine model with non-contrast-enhanced T 1 -weighted MRI. Magn Reson Med 2020; 83:1368-1379. [PMID: 31565818 PMCID: PMC6949368 DOI: 10.1002/mrm.28001] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2019] [Revised: 08/21/2019] [Accepted: 08/27/2019] [Indexed: 12/20/2022]
Abstract
PURPOSE To evaluate non-contrast-enhanced MRI of acute radio-frequency ablation (RFA) lesions in the left atrium (LA) and pulmonary vein (PV) ostia. The goal is to provide a method for discrimination between necrotic (permanent) lesions and reversible injury, which is associated with recurrence after treatment of atrial fibrillation. METHODS Fifteen normal swine underwent RFA around the right-superior PV ostia. Electrical pulmonary vein isolation (PVI) was verified by electro-anatomic mapping (EAM) and pacing. MRI was carried out using a 3D respiratory-gated T1 -weighted long inversion time (TWILITE) sequence without contrast agent. Key settings were: inversion time 700 ms, triggering over 2 cardiac cycles, pixel size 1.1 mm3 . Contrast-enhanced imaging and T2 -weighted imaging were carried out for comparison. Six animals were sacrificed on ablation day for TTC-stained gross pathology, 9 animals were sacrificed after 2-3 mo after repeat EAM and MRI. Image intensity ratio (IIR) was used to measure lesion enhancement, and gross pathology was used to validate image enhancement patterns and compare lesion widths. RESULTS RFA lesions exhibited unambiguous enhancement in acute TWILITE imaging (IIR = 2.34 ± 0.49 at 1.5T), and the enhancement patterns corresponded well with gross pathology. Lesion widths in MRI correlated well with gross pathology (R2 = 0.84), with slight underestimation by 0.9 ± 0.5 mm. Lesion enhancement subsided chronically. CONCLUSION TWILITE imaging allowed acute detection of permanent RFA lesions in swine LA and PV ostia, without the need for contrast agent. Lesion enhancement pattern showed good correspondence to gross pathology and was well visualized by volume rendering. This method may provide valuable intra- or post-procedural assessment of RFA treatment.
Collapse
Affiliation(s)
- Michael A Guttman
- Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland
| | - Susumu Tao
- Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland
| | - Sarah Fink
- Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland
| | - Rick Tunin
- Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland
| | - Ehud J Schmidt
- Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland
| | - Daniel A Herzka
- Cardiovascular Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland
| | - Henry R Halperin
- Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland
- Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland
| | - Aravindan Kolandaivelu
- Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland
| |
Collapse
|
4
|
Affiliation(s)
- Thomas F Lüscher
- Professor of Cardiology, Imperial College and Director of Research, Education & Development, Royal Brompton and Harefield Hospitals London, UK.,Professor and Chairman, Center for Molecular Cardiology, University of Zurich, Switzerland.,Editor-in-Chief, EHJ Editorial Office, Zurich Heart House, Hottingerstreet 14, Zurich, Switzerland
| |
Collapse
|